Ligand Pharmaceuticals
LGND
LGND
251 hedge funds and large institutions have $2.19B invested in Ligand Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 89 increasing their positions, 97 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
251
Holders Change
-10
Holders Change %
-3.83%
% of All Funds
5.08%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.06%
New
30
Increased
89
Reduced
97
Closed
39
Calls
$12.7M
Puts
$120M
Net Calls
-$107M
Net Calls Change
-$6.51M
Top Buyers
Top Sellers
1 |
Ameriprise
Minneapolis,
Minnesota
|
-$23.9M |
2 |
Renaissance Technologies
New York
|
-$15.2M |
3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$11.4M |
4 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$9.84M |
5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$9.41M |